New Psychiatric Medications (Part Two)
New approaches to psychosis and schizophrenia treat symptoms without the side effects of traditional dopamine blockers; the potential for psychedelics to normalize brain function in depression within a psychotherapy framework; possible psychiatric use of GLP-1 medication to manage side effects and symptoms. Guest: John Krystal, MD., Chair, Department of Psychiatry, Yale School of Medicine.
PBS PASSPORT
Stream tens of thousands of hours of your PBS and local favorites with WETA+ and PBS Passport whenever and wherever you want. Catch up on a single episode or binge-watch full seasons before they air on TV.